Show simple item record

Real world escalated Beacopdac delivers similar outcomes to escalated Beacopp and superior outcomes to response-adapted (RATHL) ABVD, while potentially reducing toxicity compared with escalated Beacopp

dc.contributor.authorSantarsieri, A.
dc.contributor.authorSturgess, K.
dc.contributor.authorBrice, P.
dc.contributor.authorMenne, T. F.
dc.contributor.authorOsborne, W.
dc.contributor.authorCreasey, T.
dc.contributor.authorArdeshna, K. M.
dc.contributor.authorBehan, S.
dc.contributor.authorBhuller, K.
dc.contributor.authorBooth, S.
dc.contributor.authorCollins, G. P.
dc.contributor.authorCwynarski, K.
dc.contributor.authorDavies, A.
dc.contributor.authorFurtado, M.
dc.contributor.authorGallop-Evans, E.
dc.contributor.authorHodson, A.
dc.contributor.authorIyengar, S.
dc.contributor.authorJones, S. G.
dc.contributor.authorLinton, Kim M
dc.contributor.authorMartinez-Calle, N.
dc.contributor.authorMcKay, P.
dc.contributor.authorNagumantry, S. K.
dc.contributor.authorO'Mahony, D.
dc.contributor.authorPhillips, B.
dc.contributor.authorPhillips, N.
dc.contributor.authorRudge, J. F.
dc.contributor.authorShah, N.
dc.contributor.authorStafford, G.
dc.contributor.authorSternberg, A.
dc.contributor.authorTrickey, R.
dc.contributor.authorUttenthal, B. J.
dc.contributor.authorWetherall, N.
dc.contributor.authorMcMillan, A. K.
dc.contributor.authorFollows, G. A.
dc.date.accessioned2022-10-19T13:13:18Z
dc.date.available2022-10-19T13:13:18Z
dc.date.issued2021en
dc.identifier.citationSantarsieri A, Sturgess K, Brice P, Menne TF, Osborne W, Creasey T, et al. Real World Escalated Beacopdac Delivers Similar Outcomes to Escalated Beacopp and Superior Outcomes to Response-Adapted (RATHL) ABVD, While Potentially Reducing Toxicity Compared with Escalated Beacopp. Blood. 2021 Nov;138. PubMed PMID: WOS:000736398803175.en
dc.identifier.doi10.1182/blood-2021-146242en
dc.identifier.urihttp://hdl.handle.net/10541/625634
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1182/blood-2021-146242en
dc.titleReal world escalated Beacopdac delivers similar outcomes to escalated Beacopp and superior outcomes to response-adapted (RATHL) ABVD, while potentially reducing toxicity compared with escalated Beacoppen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentDepartment of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridgeen
dc.identifier.journalBlooden
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record